cp-55,940 has been researched along with anandamide in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Blond, O; Briley, EM; Felder, CC; Joyce, KE; Lai, Y; Ma, AL; Mackie, K; Mansouri, J; Mitchell, RL | 1 |
| Abood, ME; Compton, DR; Martin, BR; Showalter, VM | 1 |
| Fan, P; Goutopoulos, A; Khanolkar, AD; Lin, S; Makriyannis, A; Papahadjis, D; Qin, C | 1 |
| Bianchi, A; Cruciani, G; Fichera, M; Musumarra, G | 1 |
| Fernández-Ruiz, J; González, S; Lastres-Becker, I; López-Rodríguez, ML; Ortega-Gutiérrez, S; Ramos, JA; Viso, A | 1 |
| Fowler, CJ; Lambert, DM | 1 |
| Buonerba, M; Cascio, MG; Cavallo, P; De Martino, G; Di Marzo, V; Saturnino, C; Urbani, P | 1 |
| Gynther, J; Järvinen, T; Lahtela-Kakkonen, M; Laitinen, JT; Nevalainen, T; Parkkari, T; Poso, A; Salo, OM; Savinainen, JR | 1 |
| Drmota, T; Elebring, T; Greasley, PJ; Hermansson, NO; Hjorth, S; Larsson, N; Leonova, J; Nilsson, K; Ryberg, E; Sjögren, S | 1 |
| Allarà, M; Appendino, G; Cascio, MG; De Petrocellis, L; Di Marzo, V; Ligresti, A; Minassi, A; Pertwee, RG; Taglialatela-Scafati, O | 1 |
| Aiello, F; Biotti, I; Brizzi, A; Brizzi, V; Cascio, MG; Corelli, F; Di Marzo, V; Frosini, M; Ligresti, A; Pertwee, RG | 1 |
| Buzard, DJ; Han, S; Jones, RM; Thatte, J | 1 |
| Aiello, F; Brizzi, A; Brizzi, V; Cascio, MG; Corelli, F; De Petrocellis, L; Di Marzo, V; Lamponi, S; Ligresti, A; Luongo, L; Maione, S; Marini, P; Pertwee, RG | 1 |
| Carrillo-Salinas, FJ; Fernández-Ruiz, J; Franco, R; Gómez-Cañas, M; Goya, P; Guaza, C; Hurst, DP; Jagerovic, N; Lagartera, L; Morales, P; Navarro, G; Pazos, R; Reggio, PH | 1 |
| Chung, S; Dangott, LJ; Huang, H; Kier, AB; Landrock, D; Landrock, KK; Li, S; Martin, GG; McIntosh, AL; Schroeder, F | 1 |
| Das, A; Fan, TM; Hong, IS; Roy, J; Watson, JE | 1 |
| Aiello, F; Boccella, S; Brizzi, A; Cascio, MG; Corelli, F; De Petrocellis, L; Di Marzo, V; Frosini, M; Gado, F; Ligresti, A; Luongo, L; Maione, S; Manera, C; Marini, P; Mugnaini, C; Pertwee, RG; Pessina, F | 1 |
2 review(s) available for cp-55,940 and anandamide
| Article | Year |
|---|---|
The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
Topics: Amides; Amidohydrolases; Amines; Animals; Arachidonic Acids; Binding Sites; Cannabinoid Receptor Modulators; Drug Design; Endocannabinoids; Esters; Ethers; Glycerides; Humans; Ligands; Monoacylglycerol Lipases; Polyunsaturated Alkamides; Receptors, Cannabinoid | 2005 |
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity | 2013 |
15 other study(ies) available for cp-55,940 and anandamide
| Article | Year |
|---|---|
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Amidohydrolases; Animals; Arachidonic Acids; Base Sequence; Binding, Competitive; Calcium; Calcium Channel Blockers; Cannabinoids; CHO Cells; Cricetinae; Endocannabinoids; Enzyme Activation; Humans; Intracellular Fluid; Ion Channels; Kinetics; Mice; Molecular Sequence Data; Phospholipases; Polyunsaturated Alkamides; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Signal Transduction; Transfection | 1995 |
Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Topics: Animals; Binding, Competitive; Brain; Cannabinoids; Cell Membrane; Cells, Cultured; CHO Cells; Cricetinae; Cyclohexanols; Guanine Nucleotides; Humans; Ligands; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Recombinant Proteins; Sodium; Structure-Activity Relationship; Transfection | 1996 |
Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
Topics: Amidohydrolases; Animals; Arachidonic Acids; Brain; Cannabinoids; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Mice; Polyunsaturated Alkamides; Radioligand Assay; Rats; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Serine Proteinase Inhibitors; Spleen; Structure-Activity Relationship; Tosyl Compounds | 1998 |
A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors.
Topics: Arachidonic Acids; Cannabinoids; Drug Design; Endocannabinoids; Indoles; Ligands; Models, Biological; Models, Molecular; Polyunsaturated Alkamides; Receptors, Cannabinoid; Receptors, Drug; Structure-Activity Relationship | 2000 |
Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.
Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cannabinoids; Carrier Proteins; Cell Line; Cerebellum; Drug Design; Endocannabinoids; Furans; Humans; In Vitro Techniques; Membranes; Polyunsaturated Alkamides; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Spinal Cord; Structure-Activity Relationship | 2001 |
New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies.
Topics: Amides; Amidohydrolases; Arachidonic Acid; Arachidonic Acids; Cannabinoid Receptor Modulators; Cannabinoids; Cell Line; Chemistry, Pharmaceutical; Chromatography; Drug Design; Endocannabinoids; Fatty Acids; Humans; Inhibitory Concentration 50; Kinetics; Ligands; Models, Chemical; Polyunsaturated Alkamides; Protein Binding; Protein Structure, Tertiary; Receptors, Cannabinoid; Recombinant Proteins | 2006 |
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.
Topics: Animals; Cannabinoid Receptor Modulators; Cerebellum; GTP-Binding Proteins; In Vitro Techniques; Ligands; Male; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2006 |
The orphan receptor GPR55 is a novel cannabinoid receptor.
Topics: Amino Acid Sequence; Animals; Arachidonic Acids; Binding Sites; Binding, Competitive; Cannabidiol; Cannabinoids; Cell Line; Cloning, Molecular; Cyclohexanols; Down-Regulation; Endocannabinoids; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Ligands; Mice; Molecular Sequence Data; Organ Specificity; Polymerase Chain Reaction; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid; Receptors, G-Protein-Coupled; RNA, Messenger; Signal Transduction; Structure-Activity Relationship | 2007 |
Conformationally constrained fatty acid ethanolamides as cannabinoid and vanilloid receptor probes.
Topics: Amides; Animals; Cell Line; Fatty Acids; Humans; Ligands; Molecular Conformation; Protein Binding; Receptors, Cannabinoid; Stereoisomerism; Substrate Specificity; TRPV Cation Channels | 2009 |
Resorcinol-sn-glycerol derivatives: novel 2-arachidonoylglycerol mimetics endowed with high affinity and selectivity for cannabinoid type 1 receptor.
Topics: Animals; Arachidonic Acids; Brain; CHO Cells; Cricetinae; Cricetulus; Cytochrome P-450 CYP3A; Endocannabinoids; Esterases; Esters; Ethers; Glycerides; HEK293 Cells; Humans; In Vitro Techniques; Mice; Molecular Mimicry; Monoglycerides; Phenols; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Resorcinols; Stereoisomerism; Structure-Activity Relationship | 2011 |
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
Topics: Analgesics; Animals; Calcium Channels; Cell Survival; Cells, Cultured; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Humans; Ligands; Male; Mice; Molecular Structure; Nerve Tissue Proteins; NIH 3T3 Cells; Nociception; Pain; Pain Measurement; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Resorcinols; Structure-Activity Relationship; Transient Receptor Potential Channels; TRPA1 Cation Channel | 2014 |
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis.
Topics: Dose-Response Relationship, Drug; HEK293 Cells; Humans; Models, Molecular; Molecular Structure; Multiple Sclerosis; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship | 2016 |
FABP1: A Novel Hepatic Endocannabinoid and Cannabinoid Binding Protein.
Topics: Animals; Endocannabinoids; Fatty Acid-Binding Proteins; Female; Fluorescent Dyes; Humans; Liver; Male; Mice; Mice, Inbred C57BL; Receptors, Cannabinoid | 2016 |
Antitumorigenic Properties of Omega-3 Endocannabinoid Epoxides.
Topics: Amides; Amidohydrolases; Antineoplastic Agents; Apoptosis; Carcinogenesis; Cell Cycle; Cell Line, Tumor; Cell Survival; Endocannabinoids; Epoxy Compounds; Humans; Hydrolysis; Lung; Neoplasm Metastasis; Osteosarcoma; Stereoisomerism; Wound Healing | 2018 |
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity.
Topics: Amides; Analgesics; Animals; Cell Line; Dose-Response Relationship, Drug; Humans; Male; Mice; Molecular Structure; Rats; Receptors, Cannabinoid; Resorcinols; Structure-Activity Relationship; TRPV Cation Channels | 2020 |